boston pharmaceuticals - Search News

Order byBest matchMost fresh

News

GSK to buy liver disease drug from Boston Pharmaceuticals

GSK Buys Liver-Disease Treatment From Boston Pharmaceuticals for Up to $2 Billion

The move comes as GSK faces pressure to replenish its pipeline, with some of its top-selling drugs nearing the end of their exclusivity periods.

Continue reading

· 11h · on MSN

PharmExec · 5h

GSK Acquires Boston Pharmaceuticals’ Novel FGF21 Analog for Steatotic Liver Disease

BioPharma Dive · 6h

GSK to buy liver disease drug for $1.2B

GSK to buy experimental MASH drug for $1.2B upfront

GSK plans to purchase an experimental drug for the liver disease MASH from Boston Pharmaceuticals for $1.2 billion upfront.

16h

GSK to buy efimosfermin for up to $2 billion

GSK will buy efimosfermin, a specialty medicine used to treat liver disease from Boston Pharmaceuticals, for up to $2 billion ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results